Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TGTX
#1199
TG Therapeutics, Inc.
30.0
9
-0.36%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.36%
Monthly Change
-2.37%
6 month change
+5.28%
Cambio anual
+6.33%
Cierres anteriores
30.2
0
Open
30.0
9
Bid
Ask
Low
30.0
9
High
30.0
9
Volumen
136
Markets
Acciones
Atención Sanitaria
TGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
155.67 M
157.07 M
158.76 M
158.67 M
158.76 M
—
Valuation ratios
Enterprise value
3.45 B
4.55 B
6.13 B
5.58 B
5.66 B
21.92 B
Price to earnings ratio
206.57
200.67
157.72
94.71
12.95
466.05
Price to sales ratio
13.3
14.67
16.12
12.81
11
54.61
Price to cash flow ratio
127.72
119.11
105.32
98.15
83.35
405.93
Price to book ratio
5.09
21.7
7.49
6.27
4.36
39.82
Enterprise value to EBITDA ratio
-8 444.09
108.29
102.35
64.98
55.06
330.68
Profitability ratios
Return on assets %
0.01
0
0.01
0.04
0.38
0.43
Return on equity %
0.02
0.01
0.02
0.1
0.64
0.78
Return on invested capital %
38.64
12.57
14.03
47.45
-294.65
-220.6
Gross margin %
88.86
85.77
87.14
86.58
82.63
342.12
Operating margin %
14.82
10.55
7.13
24.69
18.16
60.52
EBITDA margin %
14.84
27.69
7.14
24.69
18.17
77.7
Net margin %
4.63
1.77
4.19
19.97
241.73
267.66
Liquidity ratios
Quick ratio
3.91
5.03
3.04
2.96
2.89
13.91
Current ratio
4.59
6.25
4.02
3.86
3.82
17.96
Inventory turnover
0.11
0.16
0.12
0.12
0.19
0.58
Asset turnover
0.17
0.19
0.2
0.21
0.19
0.78
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.42
0.42
0.37
0.35
0.24
1.38
Long term debt to total equity ratio
1.27
1.1
1.03
0.89
0.4
3.42
Per share metrics
Operating cash flow per share
0.08
0.16
0.18
-0.05
0.14
0.43
EBIT per share
0.08
0.19
0.05
0.21
0.18
0.64
EBITDA per share
0.08
0.19
0.05
0.21
0.18
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
2.12
1.94
1.7
1.72
1.11
6.46
Net current asset value per share
3.57
3.53
3.96
4.08
3.73
15.3
Tangible book value per share
1.2
1.39
1.46
1.7
3.77
8.32
Working capital per share
2.79
2.97
2.98
3.03
2.75
11.72
Book value per share
1.2
1.39
1.46
1.7
3.77
8.32
Noticias
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG no alcanza por 0,23$ las previsiones de BPA en el cuarto trimestre del año
TG earnings missed by $0.23, revenue topped estimates
TG Therapeutics afronta prueba de resultados mientras crece Briumvi
TG Therapeutics enfrenta prueba de resultados mientras Briumvi acelera
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
TG Therapeutics presenta datos de BRIUMVI en el foro ACTRIMS
TG Therapeutics presenta datos de BRIUMVI en el foro ACTRIMS
TG Therapeutics presents BRIUMVI data at ACTRIMS forum